A 46-year-old myopic man underwent uneventful cataract extraction with posterior chamber AcrySof (Alcon Laboratories, Inc) intraocular lens (IOL) placement. Ocular history was otherwise unremarkable. Seven years later, he developed transcapsular uveitis-glaucoma-hyphema syndrome

Glistenings are microvacuoles that form on hydrophobic IOLs. They're not usually visually significant. These were common with the AcrySof platform but the updated Clareon material fixed this. EnVista is also a glistening-free IOL platform. #ophthalmology #ophthotwitter

Acrysof IQ Panoptix or Symfony ? The answer depends on your lifestyle and needs. If you’re an outdoor sportsman who reads on an Ipad and doesn’t mind the possibility of occasional reading glasses, the Symfony lens may suit you. 1/2 #Symfony #PanOptix

Explantation of an AcrySof natural intraocular lens because of a color vision disturbance

An Update on ‘Monofocal-plus’ IOLs How the latest non-diffractive lenses are fitting into the field, and what results to expect. -Acrysof IQ Vivity -Tecnis Eyhance -RayOne EMV https://t.co/uQiQBnMbtn

The winner of the 2021 Prix Galien USA Award is Alcon and the AcrySof IQ PanOptics IOL. Accepting is Rob Scott, Vice President of Surgical R&D of Alcon. Rob Scott is a 1998 PhD graduate of @PurdueChemE and the @NPeppas Group. He is also a @theNAEng member. Congratulations.

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens https://t.co/tIjPHvn6Iz

Dr Kieran Darcy discusses the exciting potential of the new AcrySof IQ Vivity lens in the Latest Innovations session at #ESCRS

Listen to an expert panel as they discuss how understanding their patients' needs can lead to satisfied patients implanted with the AcrySof® IQ Vivity™ IOL. Watch now: https://t.co/3pzyZgq6Ae #ad

Congratulations to the 2021 US #PrixGalien Best Medical Technology winner Alcon for AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery.

What would you do?? A Single Piece Acrylic IOL (Acrysof TORIC) left in the sulcus. You see the patient 1 year later and they have obvious iris transillumination defects in the shape of the IOL AND elevated IOP. This is what I did: Hint...I put it in the bag #ophthotwitter

Congratulations to Alcon and 2e for AcrySof® IQ PanOptix® Trifocal Lens U.S. Consumer Launch Campaign, winner of the Initiative award for Best Direct-to-Patient Campaign. #PM360TrailblazerAwards

Alcon announced the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) have surpassed more than 1 million implants worldwide. Vivity is the most implanted EDOF IOL globally. Read More: https://t.co/KHpJEZ2evI

Fernández-Vega-Cueto et al assess in vitro optical quality and halo formation of the AcrySof IQ Vivity IOL and evaluate clinical outcomes in patients who had bilateral implantation https://t.co/XTL2tGbZxK

Congratulations to Alcon on the #PrixGalien Best Medical Technology nomination for AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery.

[#AAO2020] Devesh Varma, MD, FRCSC, reviews outcomes of a new nondiffractive #presbyopia-correcting IOL, the AcrySof IQ Vivity, from two large confirmatory studies. https://t.co/4DjCM8dIBD

Alcon expanded its AcrySof IOL portfolio with the introduction of multifocal and multifocal toric ultraviolet (UV)-absorbing IOLs, as well as the introduction of the AcrySof UV-Absorbing monofocal IOL with the UltraSert Preloaded Delivery System. https://t.co/qQaoPyzYGN

Cataract Surgery with Alcon's AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient ... https://t.co/RocltpYOBr

国内初承認！日本アルコン、白内障治療向け老視矯正3焦点眼内レンズ「AcrySof® IQ PanOptix® Trifocal」10月25日発売 https://t.co/78wMePqPvK